3. Shoes used within the trials.
Study ID | Control shoe | Comparator shoes |
Asymptomatic flat feet | ||
Wenger 1989 | usual shoes | corrective shoes, usual shoes + Helfet heel cups, usual shoes + UCBL CFO |
Gould 1989 | straight last shoes | ‐ straight last shoes plus longitudinal arch cookies ‐ orthopaedic shoes with long counters, solid shanks, Thomas heels, and 0.312 cm inside heel wedges ‐ orthopaedic shoes with long counters, solid shanks, Thomas heels, and 0.312 cm inside heel wedges, with supplemental thin longitudinal arch support |
Whitford 2007 | usual shoes | none (PFO, CFO) |
Asgaonkar 2012 | usual shoes | none (valgus insole) |
Kanatli 2016 | usual shoes | corrective shoes, i.e. custom‐made orthopaedic shoes that had 0.5 to 0.9cm longitudinal arch support and 3 to 4 mm heel wedges |
Ahn 2017 | usual shoes | none (2 CFO types) |
Khamooshi 2017 | usual shoes | none (foot, core exercises) |
Jafarnezhadgero 2018 | New Balance 759 (trainers) | New Balance 759 (trainers) |
Solanki 2020 | not stated | not stated |
Abd‐Elmonem 2021 | not stated | not stated |
Symptomatic flat feet | ||
Hsieh 2018 | usual shoes (encouraged to wear at least 5 hours daily) | usual shoes (encouraged to wear at least 5 hours daily) |
JIA | ||
Powell 2005 | new supportive athletic shoes with a medial longitudinal arch support and shock absorbing soles (cross‐training type shoes) | all children, regardless of intervention, received new athletic shoes at beginning of the study |
Coda 2014 | usual shoes | none (PFO, CPFO) |
DCD | ||
Morrison 2013 | usual shoes | none (CFO) |
Immediate effects studies | ||
Bok 2016 | usual shoes | none (3 inverted CFOs) |
Aboutorabi 2013 | no shoes (bare feet) | medical shoes, regular shoes (with FO) |
CFO:customised foot orthoses, CPFO: customised prefabricated foot orthoses; DCD: developmental co‐ordination disorder; FO: foot orthoses; JIA: juvenile idiopathic arthritis; PFO: prefabricated foot orthoses; UCBL: University of California Biomechanics Laboratory heel cup orthosis